• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>GlaxoSmithKline PLC

GlaxoSmithKline PLC

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Relvar® Ellipta® 100/25 mcg Gains Approval in Japan for Use in Patients with COPD

    Relvar® Ellipta® 100/25 mcg Gains Approval in Japan for Use in Patients with COPD

  2. Global Hepatitis Drugs Market Size, Share, Development, Growth and Demand Forecast to 2020 - Research and Markets

    Global Hepatitis Drugs Market Size, Share, Development, Growth and Demand Forecast to 2020 - Research and Markets

  3. FTSE 100 pulls back as pound strengthens, but oil shares hold gains

    FTSE 100 pulls back as pound strengthens, but oil shares hold gains

  4. LONDON MARKETS: FTSE 100 Pulls Back As Pound Strengthens, But Oil Shares Hold Gains

    LONDON MARKETS: FTSE 100 Pulls Back As Pound Strengthens, But Oil Shares Hold Gains

  5. Global Age-Related Macular Degeneration (AMD) Market Size, Share, Development, Growth and Demand Forecast to 2022 - Research and Markets

    Global Age-Related Macular Degeneration (AMD) Market Size, Share, Development, Growth and Demand Forecast to 2022 - Research and Markets

  6. GlaxoSmithKline Starts Phase III Studies with Daprodustat

    GlaxoSmithKline Starts Phase III Studies with Daprodustat

  7. GSK Files Regulatory Submission in US for Once-Daily Closed Triple Combination Therapy FF/UMEC/VI for Patients with COPD

    GSK Files Regulatory Submission in US for Once-Daily Closed Triple Combination Therapy FF/UMEC/VI for Patients with COPD

  8. Pneumocystis carinii Pneumonia Global Clinical Trials Review, H2, 2016 - Analysis, Technologies & Forecasts - Vendors: Sanofi, Pfizer, Allergan - Research and Markets

    Pneumocystis carinii Pneumonia Global Clinical Trials Review, H2, 2016 - Analysis, Technologies & Forecasts - Vendors: Sanofi, Pfizer, Allergan - Research and Markets

  9. News Highlights: Top Equities Stories of the Day

    News Highlights: Top Equities Stories of the Day

  10. News Highlights: Top Equities Stories of the Day

    News Highlights: Top Equities Stories of the Day

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.